» Authors » Hae Yong Yoo

Hae Yong Yoo

Explore the profile of Hae Yong Yoo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 1443
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim H, Lim H, Yoo H
Int J Mol Sci . 2024 Dec; 25(23). PMID: 39684807
Various DNA damage checkpoint control mechanisms in eukaryotic cells help maintain genomic integrity. Among these, NBS1, a key component of the MRE11-RAD50-NBS1 (MRN) complex, is an essential protein involved in...
2.
Choi S, Cho K, Kim E, Yoo H
Int J Biochem Cell Biol . 2022 Jan; 143:106152. PMID: 34974185
MDC1, a mediator of DNA damage response, recruits other repair proteins on double-strand break (DSB) sites. MDC1 is necessary for activating checkpoint kinases Chk1 and Chk2. It is unclear whether...
3.
Kang J, Lee S, Lee J, Choi M, Cho J, Kim S, et al.
BMC Cancer . 2021 Jan; 21(1):82. PMID: 33468080
Background: BCOR acts as a corepressor of BCL6, a potent oncogenic protein in cancers of the lymphoid lineage. We have found the recurrent somatic mutation of BCOR occurred in mature...
4.
Lee G, Jun Y, Yoo H, Jeon Y, Lee D, Lee S, et al.
Oncoimmunology . 2020 Sep; 9(1):1746553. PMID: 32923110
A missense mutation in encoding p.Gly17 Val has been reported to occur frequently in angioimmunoblastic T-cell lymphoma (AITL). Here, we describe a murine model which expresses the human mutant gene...
5.
Kim S, Kim U, Yoo H, Choi Y, Kang K
Int J Mol Sci . 2020 Jun; 21(12). PMID: 32575557
Double-hit lymphoma (DHL) and double-expressor lymphoma (DEL) are aggressive forms of lymphoma that require better treatments to improve patient outcomes. CKD-581 is a new histone deacetylase (HDAC) inhibitor that exhibited...
6.
Cho I, Yoon N, Hyeon J, Sim J, Yoo H, Kim S, et al.
Appl Immunohistochem Mol Morphol . 2020 Apr; 28(10):731-740. PMID: 32287077
In the era of precision medicine, accurate and reproducible assignment of cell-of-origin (COO) in diffuse large B-cell lymphoma patients has become important. The Lymph2Cx assay is accurately determining COO by...
7.
Jung H, Yoo H, Lee S, Shin S, Kim S, Lee S, et al.
Oncotarget . 2018 Sep; 9(67):32882. PMID: 30214692
[This corrects the article DOI: 10.18632/oncotarget.14928.].
8.
Hyeon J, Lee B, Shin S, Yoo H, Kim S, Kim W, et al.
Mod Pathol . 2018 May; 31(9):1418-1428. PMID: 29765142
Gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue is a distinct entity in that Helicobacter pylori infection plays the most important causative role in the development of the disease....
9.
Yoon N, Ahn S, Yoo H, Kim S, Kim W, Ko Y
Oncotarget . 2017 Apr; 8(13):22014-22022. PMID: 28423544
Diffuse large B-cell lymphomas (DLBCLs) are clinically heterogeneous and need a biomarker that can predict the outcome of treatments accurately. To assess the prognostic significance of the cell-of-origin type for...
10.
Jung H, Yoo H, Lee S, Shin S, Kim S, Lee S, et al.
Oncotarget . 2017 Feb; 8(10):17038-17049. PMID: 28152507
Ocular marginal zone lymphoma is a common type of low-grade B-cell lymphoma. To investigate the genomic changes that occur in ocular marginal zone lymphoma, we analyzed 10 cases of ocular...